Activated AMPK and prostaglandins are involved in the response to conjugated linoleic acid and are sufficient to cause lipid reductions in adipocytes

Journal of Nutritional Biochemistry

Volumn 22, Issue 7, 2011, Pages 656-664

  Jiang, Shan ^a   Chen, Han ^a   Wang, Zhigang ^a   Riethoven, Jean Jack ^a   Xia, Yuannan ^a   Miner, Jess ^a   Fromm, Michael ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Adipocyte; AMPK; CLA; Metformin; Phenformin; Prostaglandin

Indexed keywords

10,12 CONJUGATED LINOLEIC ACID; CYCLOOXYGENASE 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LINOLEIC ACID; METFORMIN; PHENFORMIN; PROSTAGLANDIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL STRAIN 3T3; ENZYME ACTIVITY; ENZYME INHIBITION; INFLAMMATION; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; STRESS; TRIACYLGLYCEROL BLOOD LEVEL;

3T3-L1 CELLS; ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; INFLAMMATION; LINOLEIC ACIDS, CONJUGATED; METFORMIN; MICE; PHENFORMIN; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958786534     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.05.005     Document Type: Article

References (51)

1. Park Y., Storkson J.M., Albright K.J., Liu W., Pariza M.W. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999, 34:235-241.
2. Park Y., Albright K.J., Liu W., Storkson J.M., Cook M.E., Pariza M.W. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997, 32:853-858.
3. Chung S., Brown J.M., Provo J.N., Hopkins R., McIntosh M.K. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem 2005, 280:38445-38456.
4. House R.L., Cassady J.P., Eisen E.J., McIntosh M.K., Odle J. Conjugated linoleic acid evokes de-lipidation through the regulation of genes controlling lipid metabolism in adipose and liver tissue. Obes Rev 2005, 6:247-258.
5. LaRosa P.C., Riethoven J.J., Chen H., Xia Y., Zhou Y., Chen M., et al. trans-10, cis-12 Conjugated linoleic acid activates the integrated stress response pathway in adipocytes. Physiol Genomics 2007, 31:544-553.
6. Kennedy A., Overman A., Lapoint K., Hopkins R., West T., Chuang C.C., et al. Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J Lipid Res 2009, 50:225-232.
7. Ou L., Wu Y., Ip C., Meng X., Hsu Y.C., Ip M.M. Apoptosis induced by t10,c12-conjugated linoleic acid is mediated by an atypical endoplasmic reticulum stress response. J Lipid Res 2008, 49:985-994.
8. Chung S., Brown J.M., Sandberg M.B., McIntosh M. trans-10,cis-12 CLA increases adipocyte lipolysis and alters lipid droplet-associated proteins: role of mTOR and ERK signaling. J Lipid Res 2005, 46:885-895.
9. Jiang S., Wang Z., Riethoven J.J., Xia Y., Miner J., Fromm M. Conjugated linoleic acid activates AMP-activated protein kinase and reduces adiposity more effectively when used with metformin in mice. J Nutr 2009, 139:2244-2251.
10. Wendel A.A., Purushotham A., Liu L.F., Belury M.A. Conjugated linoleic acid induces uncoupling protein 1 in white adipose tissue of ob/ob mice. Lipids 2009.
11. Hardie D.G. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 2008, 32(Suppl 4):S7-12.
12. Daval M., Foufelle F., Ferre P. Functions of AMP-activated protein kinase in adipose tissue. J Physiol 2006, 574:55-62.
13. Park S.H., Gammon S.R., Knippers J.D., Paulsen S.R., Rubink D.S., Winder W.W. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol 2002, 92:2475-2482.
14. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
15. Dagon Y., Avraham Y., Berry E.M. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun 2006, 340:43-47.
16. Wek R.C., Jiang H.Y., Anthony T.G. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 2006, 34:7-11.
17. House R.L., Cassady J.P., Eisen E.J., Eling T.E., Collins J.B., Grissom S.F., et al. Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol Genomics 2005, 21:351-361.
18. Poirier H., Shapiro J.S., Kim R.J., Lazar M.A. Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 2006, 55:1634-1641.
19. LaRosa P.C., Miner J., Xia Y., Zhou Y., Kachman S., Fromm M.E. trans-10, cis-12 Conjugated linoleic acid causes inflammation and delipidation of white adipose tissue in mice: a microarray and histological analysis. Physiol Genomics 2006, 27:282-294.
20. Cawthorn W.P., Sethi J.K. TNF-alpha and adipocyte biology. FEBS Lett 2008, 582:117-131.
21. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 2008, 77:289-312.
22. Hargrave-Barnes K.M., Azain M.J., Miner J.L. Conjugated linoleic acid-induced fat loss dependence on Delta6-desaturase or cyclooxygenase. Obesity (Silver Spring) 2008, 16:2245-2252.
23. Wymann M.P., Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008, 9:162-176.
24. Liu L., Clipstone N.A. Prostaglandin F2alpha induces the normoxic activation of the hypoxia-inducible factor-1 transcription factor in differentiating 3T3-L1 preadipocytes: Potential role in the regulation of adipogenesis. J Cell Biochem 2008, 105:89-98.
25. Green H., Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5:19-27.
26. Hamm J.K., Park B.H., Farmer S.R. A role for C/EBPbeta in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 preadipocytes. J Biol Chem 2001, 276:18464-18471.
27. Wen Y., Gu J., Vandenhoff G.E., Liu X., Nadler J.L. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. Am J Physiol Heart Circ Physiol 2008, 294:H1933-1938.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
29. Wu Z., Irizarry R., Gentleman R.C., Martinez-Murillo F., Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004, 99:909-917.
30. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. Article3.
31. Benjamini Y., Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Royal Statist Soc B 1995, 57:289-300.
32. Steinberg G.R., Watt M.J., Febbraio M.A. Cytokine regulation of AMPK signalling. Front Biosci 2009, 14:1902-1916.
33. Ruan H., Hacohen N., Golub T.R., Van Parijs L., Lodish H.F. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 2002, 51:1319-1336.
34. Basu S. Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation. Med Res Rev 2007, 27:435-468.
35. Chou W.L., Chuang L.M., Chou C.C., Wang A.H., Lawson J.A., FitzGerald G.A., et al. Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation. J Biol Chem 2007, 282:18162-18172.
36. Kennedy A., Chung S., LaPoint K., Fabiyi O., McIntosh M.K. trans-10, cis-12 Conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. J Nutr 2008, 138:455-461.
37. Terpstra A.H., Beynen A.C., Everts H., Kocsis S., Katan M.B., Zock P.L. The decrease in body fat in mice fed conjugated linoleic acid is due to increases in energy expenditure and energy loss in the excreta. J Nutr 2002, 132:940-945.
38. Hardie D.G. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007, 47:185-210.
39. Carter D.A. Rhythms of cellular immediate-early gene expression: more than just an early response. Exp Physiol 1997, 82:237-244.
40. Shi H., Cave B., Inouye K., Bjorbaek C., Flier J.S. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 2006, 55:699-707.
41. Zvonic S., Hogan J.C., Arbour-Reily P., Mynatt R.L., Stephens J.M. Effects of cardiotrophin on adipocytes. J Biol Chem 2004, 279:47572-47579.
42. El-Mir M.Y., Nogueira V., Fontaine E., Averet N., Rigoulet M., Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000, 275:223-228.
43. Owen M.R., Doran E., Halestrap A.P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000, 348(Pt 3):607-614.
44. Plourde M., Jew S., Cunnane S.C., Jones P.J. Conjugated linoleic acids: why the discrepancy between animal and human studies?. Nutr Rev 2008, 66:415-421.
45. Goedecke J.H., Rae D.E., Smuts C.M., Lambert E.V., O'Shea M. Conjugated linoleic acid isomers, t10c12 and c9t11, are differentially incorporated into adipose tissue and skeletal muscle in humans. Lipids 2009, 44:983-988.
46. Luft D., Schmulling R.M., Eggstein M. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases. Diabetologia 1978, 14:75-87.
47. Bailey C.J., Turner R.C. Metformin. N Engl J Med 1996, 334:574-579.
48. Hart A., Cohen H. Treatment of obese non-diabetic patients with phenformin. A double-blind cross-over trial. Br Med J 1970, 1:22-24.
49. Desilets A.R., Dhakal-Karki S., Dunican K.C. Role of metformin for weight management in patients without type 2 diabetes. Ann Pharmacother 2008, 42:817-826.
50. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol Rev 2009, 89:1025-1078.
51. Matsuoka T., Narumiya S. Prostaglandin receptor signaling in disease. Scientific World Journal 2007, 7:1329-1347.